首页> 外文期刊>Hepatitis Monthly >Efficacy of Hepatitis B Vaccination in Under Five-Year-Old Children in Iran: A Systematic Review and Meta-Analysis Study
【24h】

Efficacy of Hepatitis B Vaccination in Under Five-Year-Old Children in Iran: A Systematic Review and Meta-Analysis Study

机译:伊朗五岁以下儿童乙肝疫苗接种的有效性:系统评价和荟萃分析研究

获取原文
       

摘要

Context: Hepatitis B viral infection, specially in children, is an unsolved global health issue. National and international vaccination programs, as the main means to prevent this infection, have been operating for years. This meta-analysis study was launched to investigate the vaccination efficacy in under five-year-old children in Iran. Evidence Acquisition: In this research, all national databases including, SID, Magiran, Iran medex, Iran doc, and Medlib, as well as international databases, including PubMed, Medline, and ISI were searched for published articles associated with evaluation of seroconversion rates after hepatitis-B vaccination in Iranian children. The search was performed in the Persian and/or English language and in under five-year-old children in Iran. The variance of each study was calculated using the binomial distribution formula. The results of studies were combined using random-effects meta-analysis model. Data were analyzed using STATA version 12. Results: In the present research, 11 studies, performed from 2000 to 2017, were investigated. The number of samples in these 11 studies were 3063 children (1592 males and 1471 females). In the studies, the efficacy range of the hepatitis-B vaccine in under five-year-old children in Iran was 89% (95% CI: 86% - 93%) with high heterogeneity (P value for heterogeneity was 0.001, I2 = 92.9). Range of efficacy for males and females was 85% (95% CI: 78 to 91) and 88% (95% CI: 83 to 93), respectively. Conclusions: The hepatitis B virus (HBV) vaccination program in Iran seems to be highly effective although some questions, such as the effect of gender on responsiveness to vaccine and heterogeneity of different data, remain unclear.
机译:背景:乙肝病毒感染(尤其是儿童)是尚未解决的全球健康问题。作为预防这种感染的主要手段的国家和国际疫苗接种计划已经实施了多年。这项荟萃分析研究旨在调查伊朗5岁以下儿童的疫苗接种效果。证据采集:在本研究中,搜索了所有国家数据库(包括SID,Magiran,伊朗medex,伊朗doc和Medlib)以及国际数据库(包括PubMed,Medline和ISI),以查找与评估血清转化率相关的已发表文章。伊朗儿童接受乙肝疫苗接种。搜索使用波斯语和/或英语,以及伊朗的五岁以下儿童进行。使用二项分布公式计算每个研究的方差。研究结果使用随机效应荟萃分析模型进行合并。使用STATA版本12分析数据。结果:在本研究中,调查了2000年至2017年进行的11项研究。在这11项研究中,样本数量为3063名儿童(男性为1592名,女性为1471名)。在研究中,乙型肝炎疫苗在伊朗5岁以下儿童中的疗效范围为89%(95%CI:86%-93%),且异质性很高(异质性的P值为0.001,I < sup> 2 = 92.9)。男性和女性的疗效范围分别为85%(95%CI:78至91)和88%(95%CI:83至93)。结论:尽管尚不清楚诸如性别对疫苗反应性的影响和不同数据的异质性等一些问题,但伊朗的乙肝病毒(HBV)疫苗接种计划似乎非常有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号